Galmed Pharmaceuticals Ltd. (GLMD) DCF Valuation

Galmed Pharmaceuticals Ltd. (GLMD) Valoración de DCF

IL | Healthcare | Biotechnology | NASDAQ
Galmed Pharmaceuticals Ltd. (GLMD) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Galmed Pharmaceuticals Ltd. (GLMD) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Obtenga información sobre su análisis de valoración de Galmed Pharmaceuticals Ltd. (GLMD) utilizando nuestra calculadora DCF de última generación! Precedido con datos de GLMD reales, esta plantilla de Excel le permite ajustar los pronósticos y supuestos para determinar con precisión el valor intrínseco de Galmed Pharmaceuticals Ltd.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -22.3 -30.2 -32.8 -17.6 -6.9 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -22.4 -30.2 -32.9 -17.7 -6.9 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 75.5 50.9 34.8 13.8 12.6 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .2
Account Receivables, % 100 100 100 100 100
Inventories -27.9 -3.8 -.9 .1 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable 6.0 7.0 4.9 2.6 1.9 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -20.3 -29.0 -32.4 -18.3 -6.9 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF 13.7 -52.1 -37.4 -21.7 -7.6 -1.7 .0 .0 .0 .0
WACC, % 9.08 9.16 9.2 9.22 9.22 9.18 9.18 9.18 9.18 9.18
PV UFCF
SUM PV UFCF -1.6
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -2
Net Debt -3
Equity Value 1
Diluted Shares Outstanding, MM 0
Equity Value Per Share 5.42

What You Will Get

  • Real GLMD Financial Data: Pre-filled with Galmed Pharmaceuticals’ historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Galmed Pharmaceuticals’ intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • 🔍 Real-Life GLMD Financials: Pre-filled historical and projected data for Galmed Pharmaceuticals Ltd.
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Galmed’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Galmed’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • Download: Obtain the pre-prepared Excel file containing Galmed Pharmaceuticals Ltd.'s (GLMD) financial data.
  • Customize: Modify projections, such as revenue growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Generate various projections and instantly compare the results.
  • Make Decisions: Leverage the valuation outcomes to inform your investment choices.

Why Choose Galmed Pharmaceuticals Ltd. (GLMD) Calculator?

  • Accuracy: Utilizes real Galmed financial data for precise calculations.
  • Flexibility: Tailored for users to easily adjust and experiment with inputs.
  • Time-Saving: Avoid the complexities of creating a financial model from the ground up.
  • Professional-Grade: Crafted with the expertise and precision expected at the CFO level.
  • User-Friendly: Intuitive interface designed for all users, regardless of financial modeling skills.

Who Should Use This Product?

  • Pharmaceutical Students: Explore drug development processes and apply them using real market data.
  • Researchers: Integrate advanced models into studies or academic projects related to drug efficacy.
  • Investors: Validate your investment strategies and assess valuation scenarios for Galmed Pharmaceuticals (GLMD).
  • Market Analysts: Enhance your analysis with a ready-to-use, customizable financial model tailored for biotech firms.
  • Entrepreneurs: Understand how large pharmaceutical companies like Galmed Pharmaceuticals (GLMD) are evaluated in the market.

What the Template Contains

  • Historical Data: Includes Galmed Pharmaceuticals Ltd.’s (GLMD) past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Galmed Pharmaceuticals Ltd.’s (GLMD) intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Galmed Pharmaceuticals Ltd.’s (GLMD) financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.